Therefore, new therapeutic options, which are able to induce relaxation independent of endogenous NO, are being developed. NO-independent soluble guanylate cyclase (sGC) activators (BAY41-2272) and an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results